Menu

Researcher Publications

Salma Jabbour, MD

Selected Publications

  1. Deek MP, Benenati B, Kim S, Chen T, Ahmed I, Zou W, Aisner J, Jabbour SK. Thoracic Vertebral Body Irradiation Contributes to Acute Hematologic Toxicity During Chemoradiation Therapy for Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1):147-54.
  2. Newman NB, Sidhu MK, Baby R, Moss RA, Nissenblatt MJ, Chen T, Lu SE, Jabbour SK. Long-Term Bone Marrow Suppression During Postoperative Chemotherapy in Rectal Cancer Patients After Preoperative Chemoradiation Therapy. Int J Radiat Oncol Biol Phys. 2016 Apr 1;94(5):1052-60.
  3. Newman NB, Moss RA, Maloney-Patel N, Donohue K, Brown TV, Nissenblatt MJ, Lu SE, Jabbour SK. Bone marrow tolerance during postoperative chemotherapy in colorectal carcinomas. J Gastrointest Oncol. 2017 Jun;8(3):547-555.
  4. Yovino S; Poppe M; Jabbour S.; David V; Garofalo MC; Pandya N; Hanna N; Alexander R; Doyle A; Regine WF; Intensity-Modulated Radiation Therapy (IMRT) Significantly Improves Acute Gastrointestinal Toxicity in Pancreatic and Ampullary Cancers: A Multi-Institutional Experience; International Journal of Radiation Oncology, Biology, Physics, Volume 79, Issue 1: Pages 158-162, January 2011
  5. Deek MP, Nagarajan S, Kim S, Ahmed I, Paul S, Scher ED, Listo M, Chen A, Aisner J, Hussain S, Haffty BG, Jabbour SK. Clinical characteristics and dose-volume histogram parameters associated with the development of pleural effusions in non-small cell lung cancer patients treated with chemoradiation therapy. Acta Oncol. 2016 Aug;55(8):1029-35.
  6. Chang JY, Jabbour SK, De Ruysscher D, et al;International Particle Therapy Co-operative Group (PTCOG) Thoracic Subcommittee. Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):505-16.
  7. Deek MP, Kim S, Ahmed I, Fang BS, Zou W, Malhotra J, Aisner J, Jabbour SK. Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Non-Small Cell Lung Cancer. Am J Clin Oncol. 2016 Jun 17. [Epub ahead of print] PubMed PMID: 27322697.
  8. Gui B, Weiner AA, Nosher J, Lu SE, Foltz GM, Hasan O, Kim SK, Gendel V, Mani NB, Carpizo DR, Saad NE, Kennedy TJ, Zuckerman DA, Olsen JR, Parikh PJ, Jabbour SK. Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization. Am J Clin Oncol. 2017 Apr 17.
  9. Ahmed I, Ferro A, Baby R, Malhotra J, Cohler A, Langenfeld J, Aisner J, Zou W, Jabbour SK. Modern induction chemotherapy before chemoradiation for bulky locally-advanced nonsmall cell lung cancer improves survival. J Cancer Res Ther. 2016 Apr-Jun;12(2):952-8
  10. Jabbour SK, Hashem SA, Bosch W, Kim TK, Finkelstein SE, Anderson BM, Ben-Josef E, Crane CH, Goodman KA, Haddock MG, Herman JM, Hong TS, Kachnic LA, Mamon HJ, Pantarotto JR, Dawson LA. Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensus. Pract Radiat Oncol. 2014 Mar-Apr;4(2):82-9.
  11. Jabbour SK, Berman AT, Simone CB 2nd. Integrating immunotherapy into chemoradiation regimens for medically inoperable locally advanced non-small cell lung cancer. Transl Lung Cancer Res. 2017 Apr;6(2):113-118. doi: 10.21037/tlcr.2017.04.02.
  12. Ahmed I, Ferro A, Cohler A, Langenfeld J, Surakanti SG, Aisner J, Zou W, Haffty BG, Jabbour SK. Impact of metformin use on survival in locally-advanced, inoperable non-small cell lung cancer treated with definitive chemoradiation. J Thorac Dis. 2015 Mar;7(3):346-55.
  13. Schonewolf CA, Mehta M, Schiff D, Wu H, Haffty BG, Karantza V, Jabbour SK. Autophagy inhibition by chloroquine sensitizes HT-29 colorectal cancer cells to concurrent chemoradiation. World J Gastrointest Oncol. 2014 Mar 15;6(3):74-82.
  14. Malhotra J, Jabbour SK, Aisner J. Current state of immunotherapy for non-small cell lung cancer. Transl Lung Cancer Res. 2017 Apr;6(2):196-211. doi: 10.21037/tlcr.2017.03.01. Review. PubMed PMID: 28529902.
  15. Jamorabo DS, Lin SH, Jabbour SK. Successes and Failures of Combined Modalitiesin Upper Gastrointestinal Malignancies: New Directions. Semin Radiat Oncol. 2016 Oct;26(4):307-19. doi: 10.1016/j.semradonc.2016.05.001. Epub 2016 May 25. Review.PubMed PMID: 27619252.

Return to member profile

 

precision medicine at Rutgers Cancer Institute

 

 

 

ScreenNJ

 

 

Donate Now

 

 

 


 

 

 

 

Proud member of
Big Ten Cancer Research Consortium

 

 

Rutgers Health